The MHRA has set out the symptoms which mean some people need to get medical help as it might be 'more serious' for group of patients10:37, 01 Jun 2026People taking a common blood pressure medication have been urged to carry out an important check after a mistake was made putting some people at risk. A ramipril packaging error means some people may have been given 10mg capsules in a box labelled 2.5mg.‌Approximately 35million prescriptions for ramipril are issued across pharmacies in England every year. While just one batch of the medication is affected all users are urged to check the details of their medication and take action if they have been supplied with the affected batch.‌Medication safety experts have issued advice on what to look for on the packaging - and what to do if you have taken the affected product. The Medicines and Healthcare products Regulatory Agency has also set out symptoms of what to look out for and when to seek medical advice.‌It said: "Crescent Pharma Limited is recalling one batch of ramipril 2.5mg capsules as a precautionary measure due to a packaging error which may mean some cartons contain blister strips of a higher dose, specifically ramipril 10mg. This follows a complaint which identified that, inside a sealed carton of Crescent Pharma Limited Ramipril 2.5mg capsules, two blister strips of ramipril 10mg capsules were found by a healthcare professional."Both product batches were manufactured at the same site, and the error appears to have occurred during packaging of the cartons." Ramipril is a medicine used for the treatment of hypertension (high blood pressure), kidney disease and heart failure.‌Dr Alison Cave, MHRA Chief Safety Officer, said: "If you take Crescent Pharma Limited Ramipril 2.5mg capsules, check the packaging for batch number GR155023. The batch number and expiry date information can be found on the outer carton. If you have received this batch, check that the medication strength on the carton matches the blister strips inside."If the 2.5mg carton of Crescent Pharma Limited Ramipril contains blister strips that are labelled as Ramipril 10mg capsules, do not to take the medicine and contact your dispensing pharmacy. If the carton contains blister strips that are correctly labelled as Crescent Pharma Limited Ramipril 2.5mg capsules, you do not need to take further action and should continue to take your medicine as usual."If you have an affected pack or previously received this batch and you believe you have taken any ramipril 10mg capsules that were included in error and are currently experiencing any side effects, please seek medical advice." She went on to explain the symptoms to watch for.‌She said: "Signs and symptoms may include feeling lightheaded, fainting or being fatigued, or altered kidney function and may be more serious for vulnerable patients. Any possible impact of taking a higher dose of ramipril should be assessed by a healthcare professional to determine whether any examination or tests are needed."If you have this batch of medicine, please take the leaflet that came with your medicine and any remaining tablets with you to your pharmacy or GP practice. Any suspected side effects should also be reported via the MHRA Yellow Card scheme."‌The MHRA has advised pharmacy and healthcare professionals to stop supplying the impacted batch and return all remaining stock to their suppliers. This is not the first ramipril recall in recent weeks.In April the MHRA recalled a separate batch of the drug, also manufactured by Crescent Pharma Limited, after a different packaging mistake. This time a sealed carton of ramipril 10mg capsules was found to containt a 5mg blister pack.It said then: "Crescent Pharma Limited is recalling one batch of Ramipril 10mg Capsules as a precautionary measure due to a potential error at the manufacturing site. Crescent Pharma Limited has received one complaint to date, where it has been identified that, inside a sealed carton of Ramipril 10 mg Capsules Batch No.: GR174091, one blister pack of Ramipril 5 mg Capsules Batch No.: GR164094 was found.‌"Both product batches were manufactured at the same manufacturing site and the error appears to have occurred during secondary packaging of the cartons of Batch GR174091. Please note this is a Class 2 Patient, Pharmacy and Wholesaler level recall."Announcing that recall it said all packs from the impacted batch were being recalled as a precautionary measure. It added: "If you were prescribed Ramipril 10 mg Capsules and have received the impacted product batch (Batch Number GR174091) please check that the carton contains the correct medication. The batch number and expiry date information can be found on outer carton.Article continues below"If the carton contains blister strips that are labelled and contain Ramipril 5 mg capsule, contact your dispensing pharmacy in the first instance. If the carton contains blister strips that are labelled and contain Ramipril 10 mg Capsules, you do not need to take further action."If you are unsure or have any questions, please seek advice from your pharmacy or other healthcare professionals responsible for your care. Please take the leaflet that came with your medicine and any remaining capsules with you to your pharmacy or GP practice."In that case is advised patients any potnetial effect of a lower dose of ramipril was expected to be gradual rather than immediate or life-threatening. Anyone who experienced an adverse reaction or who had questions about the medication should seek medical attention, it added. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.